The Fast-Track Cities initiative is a global project which aims to reduce new HIV infections and AIDS-related death to zero ...
The global health organization says the lack of rapid diagnostic tests results in undertreatment and overtreatment of ...
Updated guidelines recommend fidaxomicin as the first-line agent for C difficile infection, but researchers found use in US ...
The FDA has approved Dupixent as an add-on maintenance treatment for adults with poorly controlled COPD and high counts of ...
UCB, a global biopharmaceutical company, today announced the start of BE BOLD, a head-to-head Phase 3b study, comparing BIMZELX® (bimekizumab-bkzx), an interleukin (IL)-17A and IL-17F inhibitor, with ...